Nathan
@myydraal.bsky.social
140 followers
440 following
560 posts
Posts
Media
Videos
Starter Packs
Reposted by Nathan
David Noll
@david.noll.org
· 10h
Reposted by Nathan
Zohran Mamdani campaigned a lot and appears not to hate the voters whose support he's seeking. Here's what other Democrats can learn from his unorthodox strategy.
Reposted by Nathan
Hakeem Jeffries says Zohran Mamdani is not the future of the Democratic Party.
Nathan
@myydraal.bsky.social
· 10h
Nathan
@myydraal.bsky.social
· 10h
Nathan
@myydraal.bsky.social
· 15h
Nathan
@myydraal.bsky.social
· 16h
Nathan
@myydraal.bsky.social
· 16h
Nathan
@myydraal.bsky.social
· 16h
Nathan
@myydraal.bsky.social
· 16h
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Drug, alcohol and tobacco use disorders are a global burden affecting millions of people. Despite decades of research, treatment options are sparse or missing, and relapse rates are high. Glucagon‐like peptide 1 (GLP‐1) is released in the small ...
pmc.ncbi.nlm.nih.gov
Nathan
@myydraal.bsky.social
· 16h
Nathan
@myydraal.bsky.social
· 16h
Nathan
@myydraal.bsky.social
· 16h
GLP-1 drugs' heart health benefits not solely from weight loss: study
Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.
www.medicalnewstoday.com
Nathan
@myydraal.bsky.social
· 16h
GLP-1 drugs' heart health benefits not solely from weight loss: study
Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.
www.medicalnewstoday.com
Nathan
@myydraal.bsky.social
· 16h
Nathan
@myydraal.bsky.social
· 16h
Nathan
@myydraal.bsky.social
· 16h
Nathan
@myydraal.bsky.social
· 17h
Nathan
@myydraal.bsky.social
· 17h
Nathan
@myydraal.bsky.social
· 17h
The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity rate is at 37%, down from 39.9%.
Weight loss drugs are bringing down the country's obesity rate, a survey shows
The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity rate is at 37%, down from 39.9%.
n.pr
Nathan
@myydraal.bsky.social
· 17h